Hilda Petrs-Silva

Publications

• Neuroprotective Gene Therapy by Overexpression of the Transcription Factor MAX in Rat Models of Glaucomatous Neurodegeneration
  Investigative Ophthalmology & Visual Science. 02, 2022  |   Pubmed ID: 35103748
• Mitotherapy: Unraveling a Promising Treatment for Disorders of the Central Nervous System and Other Systemic Conditions
  Cells. 07, 2021  |   Pubmed ID: 34359994
• Retinal Genomic Fabric Remodeling After Optic Nerve Injury
  Genes. 03, 2021  |   Pubmed ID: 33799827
• Neuroprotection from Optic Nerve Injury and Modulation of Oxidative Metabolism by Transplantation of Active Mitochondria to the Retina
  Biochimica Et Biophysica Acta. Molecular Basis of Disease. 05, 2020  |   Pubmed ID: 31953215
• Effects of a Combinatorial Treatment with Gene and Cell Therapy on Retinal Ganglion Cell Survival and Axonal Outgrowth After Optic Nerve Injury
  Gene Therapy. 02, 2020  |   Pubmed ID: 31243393
• A Subacute Model of Glaucoma Based on Limbal Plexus Cautery in Pigmented Rats
  Scientific Reports. 11, 2019  |   Pubmed ID: 31705136
• Retina Transduction by RAAV2 After Intravitreal Injection: Comparison Between Mouse and Rat
  Gene Therapy. 12, 2019  |   Pubmed ID: 31562387
• RAAV8-733-Mediated Gene Transfer of CHIP/Stub-1 Prevents Hippocampal Neuronal Death in Experimental Brain Ischemia
  Molecular Therapy : the Journal of the American Society of Gene Therapy. 02, 2017  |   Pubmed ID: 28153090
• CHIP, a Carboxy Terminus HSP-70 Interacting Protein, Prevents Cell Death Induced by Endoplasmic Reticulum Stress in the Central Nervous System
  Frontiers in Cellular Neuroscience. 2014  |   Pubmed ID: 25620910
• Suppression of Rds Expression by SiRNA and Gene Replacement Strategies for Gene Therapy Using RAAV Vector
  Advances in Experimental Medicine and Biology. 2012  |   Pubmed ID: 22183336
• Biosynthesis and Metabolism of Sulfated Glycosaminoglycans During Drosophila Melanogaster Development
  Glycobiology. Jun, 2004  |   Pubmed ID: 15044397